載入...
Anlotinib-induced acute myocardial infarction: A case report and literature review
Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor, which has been recently approved for the treatment of advanced non-small cell lung cancer in China. One of its mechanisms of action is the inhibition of angiogenesis and it is similar to other anti-angiogenesis drugs, as it has car...
Na minha lista:
| 發表在: | Exp Ther Med |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7444427/ https://ncbi.nlm.nih.gov/pubmed/32855689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.9041 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|